Clinical Trial

Clinical Study on the Safety and Efficacy of BCMA-CART±ASCT in Treating Young Multiple Myeloma Patients

Name: Clinical Study on the Safety and Efficacy of BCMA-CART±ASCT in Treating Young Multiple Myeloma Patients — clinical trial record (NCT07169500)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

Evaluate and compare the safety and efficacy of BCMA-CART ± ASCT in the treatment of newly diagnosed multiple myeloma (NDMM) in young patients

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-05.

Trial Details

NCT Number	NCT07169500
Lead Sponsor	Institute of Hematology & Blood Diseases Hospital, China Collaborators: Hebei Taihe Chunyu Biotechnology Co., Ltd
Conditions	Multiple Myeloma
Enrollment	50 participants
Start Date	2025-03-03
Primary Completion	2028-03-02 (estimated)
Study Completion	2030-03-02 (estimated)
Updated on ClinicalTrials.gov	2026-03-02